Poster Exhibition 1

[PE-105] Guselkumab efficacy and safety in East Asian participants with moderate to severely active ulcerative colitis: Subgroup analysis of the Phase 3 ASTRO subcutaneous induction and maintenance studies

Shigang Ding¹, Naizhong Hu², Xiaodi Wang³, Reiko Kunisaki⁴, *Ken Takeuchi⁵, Tae Oh Kim⁶, Horng-Yuan Wang⁷, Yelina Alvarez⁸, Keira Herr⁹, Jianmin Zhuo¹⁰, Tadakazu Hisamatsu¹¹ (1. Department of Gastroenterology, Peking University Third Hospital, Beijing, China, 2. Department of Gastroenterology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China, 3. Department of Gastroenterology, China Japan Friendship Hospital, Beijing, China, 4. Inflammatory Bowel Disease Center, Yokohama City University Medical Center, Yokohama, Japan, 5. Department of Gastroenterology, IBD Centre, Tsujinaka Hospital Kashiwanoha, Kashiwa, Chiba, Japan, 6. Department of Internal Medicine, Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea, 7. Division of Gastroenterology, Department of Internal Medicine, MacKay Memorial Hospital, Taipei, Taiwan, 8. Johnson & Johnson, Spring House, PA, USA, 9. Johnson & Johnson, Singapore, Singapore, 10. Johnson & Johnson, Shanghai, China, 11. Department of Gastroenterology and Hepatology, Kyorin University School of Medicine, Tokyo, Japan)

Password required to view

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.